INTRODUCTION:
A traditional orthognathic approach requires presurgical orthodontic treatment for an average of approximately 17 months, 1 followed by surgery and postsurgical orthodontic treatment for approximately 6-12 months. Therefore, the total treatment time for the conventional orthognathic approach takes approximately 18-36 months. [2] [3] [4] Because traditional orthognathic surgery requires 2-3 years to complete, it is a rarely adopted procedure. Therefore, shortening the total treatment time would be extremely beneficial for patients. Although presurgical orthodontic treatment has been approved as an inevitable process for stable orthognathic correction before surgery, recent advances in the application of mini-screws and presurgical simulational orthodontic management skills on a dental model show that it is possible to perform a surgery-first orthognathic approach without presurgical orthodontic treatment.
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MATERIALS AND METHODS:
We assessed 45 consecutive Asian patients with skeletal class III dentofacial deformities with surgery-first orthognathic surgery compared to 52 patients with conventional two-jaw orthognathic surgery. Using cephalometric landmark data for the patients with a surgery-first approach, we analyzed postoperative changes in vertical and horizontal facial, denture, and soft tissue patterns. Assuming that tooth extraction is a factor that affects the total treatment time, both groups were divided into two subgroups.
RESULTS:
The treatment duration of the surgery-first group was significantly less than that of the orthodontics-first group. Overall, the analysis revealed that the total treatment time period in the surgery-first orthognathic approach averaged 14.6 months compared to 22.0 months of treatment in an orthodontic-first orthognathic approach. Among the surgery-first cases without tooth extraction, the average treatment interval was only 13.6 months versus 24.8 months for the six that required tooth extraction (p < 0.001). In contrast, the average treatment period of traditional orthodontics-first cases without tooth extraction was roughly comparable to the nine cases that required tooth extraction (21.7 months vs. 21.6 months, respectively). The difference between immediate postoperative and preoperative, postoperative and immediate postoperative cephalometric data revealed factors that have correlation with total treatment duration.
CONCLUSION: Surgery-first orthognathic surgery can dramatically shorten the total treatment time with no major complications. By analyzing the cephalometric landmark data we identified several possible factors that have an effect on the total treatment time. (VIT) were administered at varying dose levels (5U/0.1mL bolus, 10U/0.1mL bolus, and 30U/0.1mL bolus). 3D images were captured to quantify the loss of projection at six time points over 72 hours. Histology was performed to confirm degradation at 2 weeks post-administration.
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RESULTS:
For both HA fillers, complete loss of projection was achieved with the highest dose of HX and VIT. More projection (i.e. less degradation) was detected with the lower doses of HX and VIT. No significant differences in the resulting projection were observed when comparing the effect of HX to VIT (at any dose level) or the degradation response of VYC-20L or HYC-24L+ to either hyaluronidase. The histology showed significant loss of filler material at 2 weeks, with minimal amounts of filler observed.
CONCLUSION:
The in vivo susceptibility of HA fillers to hyaluronidase-induced degradation has not been investigated previously. This novel animal model evaluated the susceptibility of fillers with different physicochemical properties to commercially-available hyaluronidases. Using an animal model allowed degradation to be evaluated while incorporating variables introduced by the biological environment (e.g. clearance, competing substrates for hyaluronidase). The results showed that the projection detected by 3D imaging was able to be reduced to non-detectable levels for both fillers. A dose-dependent response was observed, suggesting that the amount of degradation can be varied. Additionally, the same degree of degradation was observed for both commercially-available hyaluronidases and, despite differences in physicochemical properties, the same degree of degradation was achieved for both VYC-20L and HYC-24L+. These outcomes confirm that enzymatic degradation of HA by exogenous hyaluronidase is not hindered by the physicochemical properties of the fillers when evaluated in vivo.
